All News

SeaSpine to Report First Quarter 2018 Financial Results on May 3, 2018

CARLSBAD, Calif., April 19, 2018 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will release first quarter 2018 financial results after the close of trading on Thursday, May 3, 2018. The Company’s management team will host a […]

“Patch” May Help Recovery After Shoulder Surgery for Rotator Cuffs

NEW YORK AND GREENWICH, CONN. (PRWEB) APRIL 19, 2018 Shoulder injury? Get “patched up” – literally, says renowned orthopedic surgeon and sports medicine and arthroplasty specialist, Kevin D. Plancher, MD, who is using advanced technology – an all-natural, biologic “patch” about the size of a postage stamp – to repair and heal a certain type of tendon […]

RTI Surgical Schedules First Quarter 2018 Earnings Call for May 3, 2018

April 19, 2018 ALACHUA, Fla.–(BUSINESS WIRE)–RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced that it plans to release financial results for the first quarter 2018 on Thursday, May 3, 2018 prior to the market open. RTI will host a conference call and simultaneous audio webcast to discuss first quarter results at […]

Spikes of Graphene Can Kill Bacteria on Knee & Hip Implants

By Chalmers University of Technology – 04.16.18 A tiny layer of graphene flakes becomes a deadly weapon and kills bacteria, stopping infections during procedures such as implant surgery. This is the findings of new research from Chalmers University of Technology, Sweden, recently published in the scientific journal Advanced Materials Interfaces. Operations for surgical implants, such as hip and […]

Ortho Sales Partners Announces the Appointment of Chris Stewart as Senior Vice President and General Manager of Hospital Strategy

Ortho Sales Partners, the global leader in commercialization services for the orthopedic industry, is pleased to announce the addition of Chris Stewart to the companies executive team. Mr. Stewart is a very well regarded leader and innovator that brings an in-depth knowledge of the supplier, hospital and physician relationship. In addition to having a cross […]

SpineGuard® Announces First Spinal Deformity Surgery in China with PediGuard® by Prof. Yong Qiu

April 18, 2018 PARIS & SAN FRANCISCO–(BUSINESS WIRE)–Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that develops and markets instruments designed to secure the placement of surgical implants by bringing real-time digital technology into the operating room, announced today that Professor Yong QIU performed the first spinal deformity surgery in China with the PediGuard® device. […]

Histogenics Corporation Announces the Appointment of Susan Washer to Its Board of Directors

WALTHAM, Mass., April 18, 2018 (GLOBE NEWSWIRE) — Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies (RCTs) that may offer rapid-onset pain relief and restored function, today announced the appointment of Susan Washer to its Board of Directors. “Having known and worked with Sue for over 15 years, we are […]

First Case for Augmented Shoulder Baseplate

By: Elizabeth Hofheinz, M.P.H., M.Ed., April 17, 2018 Zimmer Biomet Holdings, Inc., based in Warsaw, Indiana, has announced that the first surgical case utilizing its Comprehensive Augmented Baseplate was performed by John W. Sperling, M.D., an orthopedic surgeon at Mayo Clinic. According to the company, “This newly cleared baseplate boasts a simplified circular design at […]

Johnson & Johnson Reports 2018 First-Quarter Results

NEW BRUNSWICK, N.J., April 17, 2018 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today announced sales of $20.0 billion for the first quarter of 2018, an increase of 12.6% as compared to the first quarter of 2017. Operational sales results increased 8.4% and the positive impact of currency was 4.2%. Domestic sales increased 6.1%. International sales increased 19.9%, reflecting operational growth […]

OrthoTrophix Will Present Data on Long-Term Clinical Benefit of TPX-100 in Mild to Severe Knee Osteoarthritis Patients at OARSI Annual Meeting 2018

OAKLAND, Calif., April 17, 2018 /PRNewswire/ — OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that the company plans to report long-term clinical benefits in mild to severe knee osteoarthritis (OA) patients who were treated with TPX-100 at the 2018 OARSI annual meeting (Liverpool, U.K., 26-29 April 2018). OrthoTrophix previously presented the results of a Phase 2 […]

© 2018 Powered by Careerleaf